| abstract |
The invention relates to a compound having the structure: (I) or (II) or a pharmaceutically acceptable salt or solvate thereof, or a pharmaceutically acceptable salt, the variables being defined in the specification. The invention also relates to methods of treatment as Janus Kinase inhibitors and pharmaceutical compositions containing the compounds of the invention as well as combinations thereof with other therapeutic agents. |